US Patent 7837995 Immunotherapy of B-cell malignancies using anti-CD22 antibodies
Patent 7837995 was granted and assigned to IMMUNOMEDICS, INC. on November, 2010 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 9, 2002
Date of Patent
November 23, 2010
Patent Application Number
10314330
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7837995 Immunotherapy of B-cell malignancies using anti-CD22 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.